Blood filter during heart surgery for children
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests a special blood filter used during children's heart surgery to reduce inflammation. It may help children recover faster after long operations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Children under 18 years old
- Heart surgery expected to last more than 3 hours on a heart-lung machine
- The filter is given to prevent inflammation during surgery
- Parents or guardians must give permission
- Not involved in another conflicting study
- Not having surgery without the heart-lung machine
- No anti-inflammatory medication in the last 7 days
- Not pregnant (if applicable)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how active white blood cells and inflammation are during complex heart surgery using a heart-lung machine. It may help doctors better understand what triggers inflammation during surgery and how to improve care.
This trial studies patterns in immune cells (neutrophils) in very young children who undergo heart surgery using a heart-lung machine. The goal is to better understand and potentially reduce lung injury after surgery.
This study tests whether adding a special filter (called a cytokine adsorber) to the heart-lung machine during your child's open-heart surgery can reduce harmful inflammation and help them recover better. The filter is used alongside the standard heart-lung machine during the operation.
This trial tests a blood-filtering treatment for people in septic shock, a severe reaction to infection. It aims to see if removing harmful substances from the blood can help recovery.
This trial tests a device that filters the blood during urgent heart surgery. It may help patients who take blood thinners by reducing bleeding risks during surgery.
This study looks at how managing blood products during heart surgery with a heart-lung machine affects the risk of red blood cell breakdown in children. The goal is to find safer ways to handle blood during these procedures.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.